| Title : Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies - Kanefendt_2023_Br.J.Clin.Pharmacol__ |
| Author(s) : Kanefendt F , Brase C , Jungmann N , Fricke R , Engelen A , Schmitz S |
| Ref : British Journal of Clinical Pharmacology , : , 2023 |
| Abstract : |
| PubMedSearch : Kanefendt_2023_Br.J.Clin.Pharmacol__ |
| PubMedID: 38048692 |
| Title : Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies - Kanefendt_2023_Br.J.Clin.Pharmacol__ |
| Author(s) : Kanefendt F , Brase C , Jungmann N , Fricke R , Engelen A , Schmitz S |
| Ref : British Journal of Clinical Pharmacology , : , 2023 |
| Abstract : |
| PubMedSearch : Kanefendt_2023_Br.J.Clin.Pharmacol__ |
| PubMedID: 38048692 |
| Title : Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies - Kanefendt_2023_Br.J.Clin.Pharmacol__ |
| Author(s) : Kanefendt F , Brase C , Jungmann N , Fricke R , Engelen A , Schmitz S |
| Ref : British Journal of Clinical Pharmacology , : , 2023 |
| Abstract : |
| PubMedSearch : Kanefendt_2023_Br.J.Clin.Pharmacol__ |
| PubMedID: 38048692 |